{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:01:43Z","timestamp":1790949703744,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00223-021-00935-z","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:04:01Z","timestamp":1643328241000},"page":"464-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Clinical and Radiologic Response of Central Giant Cell Granuloma to Denosumab: A 6-Year Prospective Observational Study"],"prefix":"10.1007","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4151-9282","authenticated-orcid":false,"given":"Yoon Ji Jina","family":"Rhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Jen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel A.","family":"Vanderniet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig F.","family":"Munns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedley","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3640-1370","authenticated-orcid":false,"given":"Deborah Jane","family":"Holmes-Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8746-5529","authenticated-orcid":false,"given":"Christian M.","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"issue":"1","key":"935_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0030-4220(53)90151-0","volume":"6","author":"HL Jaffe","year":"1953","unstructured":"Jaffe HL (1953) Giant-cell reparative granuloma, traumatic bone cysts, and fibrous (fibro-oseous) dysplasia of the jawbones. Oral Surg Oral Med Oral Pathol 6(1):159\u2013175. https:\/\/doi.org\/10.1016\/0030-4220(53)90151-0","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"5","key":"935_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.tripleo.2007.04.003","volume":"104","author":"J de Lange","year":"2007","unstructured":"de Lange J, van den Akker HP, van den Berg H (2007) Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104(5):603\u2013615. https:\/\/doi.org\/10.1016\/j.tripleo.2007.04.003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"9","key":"935_CR3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/0278-2391(86)90040-6","volume":"44","author":"R Chuong","year":"1986","unstructured":"Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A (1986) Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg 44(9):708\u2013713. https:\/\/doi.org\/10.1016\/0278-2391(86)90040-6","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"935_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0030-4220(93)90094-k","volume":"5","author":"SB Whitaker","year":"1993","unstructured":"Whitaker SB, Waldron CA (1993) Central giant cell lesions of the jaws. A clinical, radiologic, and histopathologic study. Oral Surg Oral Med Oral Pathol 5(2):199\u2013208. https:\/\/doi.org\/10.1016\/0030-4220(93)90094-k","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"8","key":"935_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/jop.12730","volume":"47","author":"BR Chrcanovic","year":"2018","unstructured":"Chrcanovic BR, Gomes CC, Gomez RS (2018) Central giant cell lesion of the jaws: an updated analysis of 2770 cases reported in the literature. J Oral Pathol Med 47(8):731\u2013739. https:\/\/doi.org\/10.1111\/jop.12730","journal-title":"J Oral Pathol Med"},{"issue":"9","key":"935_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/jop.12937","volume":"48","author":"BR Chrcanovic","year":"2019","unstructured":"Chrcanovic BR, Gomes CC, Dos Santos TR, Abreu MHNG, Gomez RS (2019) Clinical factors associated with the recurrence of central giant cell lesions. J Oral Pathol Med 48(9):799\u2013802. https:\/\/doi.org\/10.1111\/jop.12937","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"935_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12105-019-01086-2","volume":"14","author":"JC Lee","year":"2020","unstructured":"Lee JC, Huang HY (2020) Soft tissue special issue: giant cell-rich lesions of the head and neck region. Head Neck Pathol 14(1):97\u2013108. https:\/\/doi.org\/10.1007\/s12105-019-01086-2","journal-title":"Head Neck Pathol"},{"key":"935_CR8","doi-asserted-by":"publisher","first-page":"153303381984000","DOI":"10.1177\/1533033819840000","volume":"18","author":"E Palmerini","year":"2019","unstructured":"Palmerini E, Picci P, Reichardt P, Downey G (2019) Malignancy in giant cell tumor of bone: a review of the literature. Technol Cancer Res Treat 18:1533033819840000. https:\/\/doi.org\/10.1177\/1533033819840000","journal-title":"Technol Cancer Res Treat"},{"issue":"3","key":"935_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","volume":"11","author":"D Thomas","year":"2010","unstructured":"Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M et al (2010) Denosumab in patients with giant cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11(3):275\u2013280. https:\/\/doi.org\/10.1016\/S1470-2045(10)70010-3","journal-title":"Lancet Oncol"},{"issue":"12","key":"935_CR10","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/S1470-2045(19)30663-1","volume":"20","author":"S Chawla","year":"2019","unstructured":"Chawla S, Blay JY, Rutkowski P, Le Cesne A, Reichardt P, Gelderblom H, Grimer RJ et al (2019) Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. Lancet Oncol 20(12):1719\u20131729. https:\/\/doi.org\/10.1016\/S1470-2045(19)30663-1","journal-title":"Lancet Oncol"},{"issue":"4","key":"935_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/CCO.0000000000000529","volume":"31","author":"A Lipplaa","year":"2019","unstructured":"Lipplaa A, Dijkstra S, Gelderblom H (2019) Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone. Curr Opin Oncol 31(4):329\u2013335. https:\/\/doi.org\/10.1097\/CCO.0000000000000529","journal-title":"Curr Opin Oncol"},{"issue":"7","key":"935_CR12","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jcms.2015.04.011","volume":"43","author":"B Gupta","year":"2015","unstructured":"Gupta B, Stanton N, Coleman H, White C, Singh J (2015) A novel approach to the management of a central giant cell granuloma with denosumab: a case report and review of current treatments. J Craniomaxillofac Surg 43(7):1127\u20131132. https:\/\/doi.org\/10.1016\/j.jcms.2015.04.011","journal-title":"J Craniomaxillofac Surg"},{"issue":"7","key":"935_CR13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bjoms.2019.05.023","volume":"57","author":"M Hameed","year":"2019","unstructured":"Hameed M, O\u2019Connell JE, Rogers SN (2019) Management of an aggressive giant cell granuloma of the mandible with denosumab: a case report. Br J Oral Maxillofac Surg 57(7):691\u2013693. https:\/\/doi.org\/10.1016\/j.bjoms.2019.05.023","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"2","key":"935_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/jbm4.10010","volume":"1","author":"TS Kim","year":"2017","unstructured":"Kim TS, Usera GL, Ruggiero SL, Weinerman SA (2017) Improvement of giant cell lesions of the jaw treated with high and low doses of denosumab: a case series. JMBR Plus. 1(2):101\u2013106. https:\/\/doi.org\/10.1002\/jbm4.10010","journal-title":"JMBR Plus."},{"issue":"12","key":"935_CR15","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.joms.2014.06.456","volume":"72","author":"A Naidu","year":"2014","unstructured":"Naidu A, Malmquist MP, Denham CA, Schow SR (2014) Management of central giant cell granuloma with subcutaneous denosumab therapy. J Oral Maxillofac Surg 72(12):2469\u20132484. https:\/\/doi.org\/10.1016\/j.joms.2014.06.456","journal-title":"J Oral Maxillofac Surg"},{"issue":"8","key":"935_CR16","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.ijom.2020.12.013","volume":"50","author":"MA Pogrel","year":"2021","unstructured":"Pogrel MA, Hossaini-Zadeh M (2021) Denosumab for the management of central giant cell granuloma of the jaws-a case series. Int J Oral Maxillofac Surg 50(8):1019\u20131022. https:\/\/doi.org\/10.1016\/j.ijom.2020.12.013","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"7","key":"935_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671\u2013675. https:\/\/doi.org\/10.1038\/nmeth.2089","journal-title":"Nat Methods"},{"issue":"4","key":"935_CR18","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.joms.2017.09.013","volume":"76","author":"M Bredell","year":"2018","unstructured":"Bredell M, Rordorf T, Kroiss S, Rucker M, Zweifel DF, Rostetter C (2018) Denosumab as a treatment alternative for central giant cell granuloma: a long-term retrospective cohort study. J Oral Maxillofac Surg 76(4):775\u2013784. https:\/\/doi.org\/10.1016\/j.joms.2017.09.013","journal-title":"J Oral Maxillofac Surg"},{"issue":"7","key":"935_CR19","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.joms.2014.02.017","volume":"72","author":"WH Schreuder","year":"2014","unstructured":"Schreuder WH, Coumou AW, Kessler PA, de Lange J (2014) Alternative pharmacologic therapy for aggressive central giant cell granuloma: denosumab. J Oral Maxillofac Surg 72(7):1301\u20131309. https:\/\/doi.org\/10.1016\/j.joms.2014.02.017","journal-title":"J Oral Maxillofac Surg"},{"key":"935_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1746-160X-8-23","volume":"8","author":"NG da Silva","year":"2012","unstructured":"da Silva NG, Carreira AS, Pedreira EN, Tuji FM, Ortega KL, de Jesus Viana Pinheiro J (2012) Treatment of central giant cell lesions using bisphosphonates with intralesional corticosteroid injections. Head Face Med 8:23. https:\/\/doi.org\/10.1186\/1746-160X-8-23","journal-title":"Head Face Med"},{"issue":"5 Suppl","key":"935_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.joms.2008.12.006","volume":"67","author":"R Landesberg","year":"2009","unstructured":"Landesberg R, Eisig S, Fennoy I, Siris E (2009) Alternative indications for bisphosphonate therapy. J Oral Maxillofac Surg 67(5 Suppl):27\u201334. https:\/\/doi.org\/10.1016\/j.joms.2008.12.006","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"935_CR22","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/pbc.25393","volume":"62","author":"N Gossai","year":"2015","unstructured":"Gossai N, Hilgers MV, Polgreen LE, Greengard EG (2015) Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumour of bone. Pediatr Blood Cancer 62(6):1078\u20131080. https:\/\/doi.org\/10.1002\/pbc.25393","journal-title":"Pediatr Blood Cancer"},{"issue":"S1","key":"935_CR23","doi-asserted-by":"publisher","first-page":"A706","DOI":"10.1210\/jendso\/bvab048.1439","volume":"5","author":"I Marpuri","year":"2021","unstructured":"Marpuri I, Cheung CC, Moke DJ, Ryabets-Lienhard A (2021) Symptomatic rebound hypercalcemia after denosumab discontinuation in a pediatric patient with cherubism. J Endocr Soc. 5(S1):A706-707. https:\/\/doi.org\/10.1210\/jendso\/bvab048.1439","journal-title":"J Endocr Soc."},{"issue":"1","key":"935_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1148\/radiol.2511081300","volume":"251","author":"B Huang","year":"2009","unstructured":"Huang B, Law MW, Khong PL (2009) Whole-body PET\/CT scanning: estimation of radiation dose and cancer risk. Radiology 251(1):166\u2013174. https:\/\/doi.org\/10.1148\/radiol.2511081300","journal-title":"Radiology"},{"issue":"9","key":"935_CR25","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.14219\/jada.archive.2008.0339","volume":"139","author":"JB Ludlow","year":"2008","unstructured":"Ludlow JB, Davies-Ludlow LE, White SC (2008) Patient risk related to common dental radiographic examinations: the impact of 2007 international commission on radiological protection recommendations regarding dose calculation. J Am Dent Assoc 139(9):1237\u20131243. https:\/\/doi.org\/10.14219\/jada.archive.2008.0339","journal-title":"J Am Dent Assoc"},{"issue":"5","key":"935_CR26","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1148\/radiographics.21.5.g01se251283","volume":"21","author":"MD Murphey","year":"2001","unstructured":"Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ (2001) Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. Radiographics 21(5):1283\u20131309. https:\/\/doi.org\/10.1148\/radiographics.21.5.g01se251283","journal-title":"Radiographics"},{"issue":"2","key":"935_CR27","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.4317\/medoral.20499","volume":"20","author":"PC Edwards","year":"2015","unstructured":"Edwards PC (2015) Insight into the pathogenesis and nature of central giant cell lesions of the jaws. Med Oral Patol Oral Cir Bucal 20(2):e196-198. https:\/\/doi.org\/10.4317\/medoral.20499","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"1","key":"935_CR28","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1038\/s41467-018-06690-4","volume":"9","author":"CC Gomes","year":"2018","unstructured":"Gomes CC, Gayden T, Bajic A, Harraz OF, Pratt J, Nikbakht H, Bareke E et al (2018) TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw. Nat Commun 9(1):4572. https:\/\/doi.org\/10.1038\/s41467-018-06690-4","journal-title":"Nat Commun"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-021-00935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-021-00935-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-021-00935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T14:05:44Z","timestamp":1647439544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-021-00935-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["935"],"URL":"https:\/\/doi.org\/10.1007\/s00223-021-00935-z","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"7 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Craig F. Munns has previously been involved in an Amgen-sponsored clinical trial (not related to this manuscript). Christian M. Girgis has received an honorarium from Amgen for educational presentations on romosozumab. Yoon Ji Jina Rhou, Che-Jen Wang, Minh Nguyen, Joel A. Vanderniet, Craig F. Munns, Hedley Coleman, James Kim, Deborah Jane Holmes-Walker, Lydia Lim, and Christian M. Girgis have no other relevant financial or non-financial conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval was obtained from the Western Sydney Local Health District Human Ethics Committee and procedures followed were in accordance with the ethics standards of the committee and with the Helsinki Declaration. All data was collected as part of the participants' routine clinical management. Informed consent was obtained prior to photographing and the research participant has provided informed consent for publication of the images in Figures 4a and 4b.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent statement"}}]}}